Valma Harjutsalo

Valma Harjutsalo

Auto-generated profile, based on publicly available information

Valma Harjutsalo

Folkhälsan Research Center, Helsinki, Finland

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2013 in JAMA
Verified
Journal Article
Open access
PDF file
VHValma Harjutsalo
Valma Harjutsalo
RSReijo Sund
Reijo Sund
MKMikael Knip
Mikael Knip
PGPer-Henrik Groop
Per-Henrik Groop
The incidence of type 1 diabetes (T1D), one of the most prevalent chronic disease in children, has increased worldwide.1 The highest recorded incidence in children younger than 15 years was 64.2 per 100 000 person-years in Finland in 2005.2 We examined the incidence rates between 2006 and 2011 in Finnish children younger than 15 years as well as the 32-year trend (1980-2011).

8 September 2011 in BMJ
Verified
Journal Article
Open access
PDF file
VHValma Harjutsalo
Valma Harjutsalo
CFCarol Forsblom
Carol Forsblom
PGPer-Henrik Groop
Per-Henrik Groop
Objective To examine short and long term time trends in mortality among patients with early onset (age 0-14 years) and late onset (15-29 years) type 1 diabetes and causes of deaths over time. Design Population based nationwide cohort study. Setting Finland. Participants All Finnish patients diagnosed as having type 1 diabetes below age 30 years between 1970 and 1999 (n=17 306). Main outcome measures Crude mortality, standardised mortality ratios, time trends, and cumulative mortality. Results A total of 1338 deaths occurred during 370 733 person years of follow-up, giving an all cause mortality rate of 361/100 000 person years. The standardised mortality ratio was 3.6 in the early onset cohort and 2.8 in the late onset cohort. Women had higher standardised mortality ratios than did men in both cohorts (5.5 v 3.0 in the early onset cohort; 3.6 v 2.6 in the late onset cohort). The standardised mortality ratio at 20 years’ duration of diabetes in the early onset cohort decreased from 3.5 in the patients diagnosed in 1970-4 to 1.9 in those diagnosed in 1985-9. In contrast, the standardised mortality ratio in the late onset cohort increased from 1.4 in those diagnosed in 1970-4 to 2.9 in those diagnosed in 1985-9. Mortality due to chronic complications of diabetes decreased with time in the early onset cohort but not in the late onset cohort. Mortality due to alcohol related and drug related causes increased in the late onset cohort and accounted for 39% of the deaths during the first 20 years of diabetes. Accordingly, mortality due to acute diabetic complications increased significantly in the late onset cohort. Conclusion Survival of people with early onset type 1 diabetes has improved over time, whereas survival of people with late onset type 1 diabetes has deteriorated since the 1980s. Alcohol has become an important cause of death in patients with type 1 diabetes, and the proportion of deaths caused by acute complications of diabetes has increased in patients with late onset type 1 diabetes.

8 May 2021 in Journal of Internal Medicine
Verified
Journal Article
Open access
PDF file
FSF. Jansson Sigfrids
F. Jansson Sigfrids
EDE. H. Dahlström
E. H. Dahlström
CFC. Forsblom
C. Forsblom
NSN. Sandholm
N. Sandholm
VHV. Harjutsalo
V. Harjutsalo
PGPer-Henrik Groop
Per-Henrik Groop
Background: We aimed to assess whether remnant cholesterol concentration and variability predict the progression of diabetic nephropathy (DN) and severe diabetic retinopathy (SDR) in type 1 diabetes.Methods: This observational prospective study covered 5150 FinnDiane Study participants. Remnant cholesterol was calculated as total cholesterol – LDL cholesterol – HDL cholesterol and variability as the coefficient of variation. DN category was based on consensus albuminuria reference limits and the progression status was confirmed from medical files. SDR was defined as retinal laser treatment. For 1338 individuals, the severity of diabetic retinopathy (DR) was graded using the ETDRS classification protocol. Median (IQR) follow‐up time was 8.0 (4.9–13.7) years for DN and 14.3 (10.4–16.3) for SDR.Results: Remnant cholesterol (mmol L−1) was higher with increasing baseline DN category (P < 0.001). A difference was also seen comparing non‐progressors (0.41 [0.32–0.55]) with progressors (0.55 [0.40–0.85]), P < 0.001. In a Cox regression analysis, remnant cholesterol predicted DN progression, independently of diabetes duration, sex, HbA1c, systolic blood pressure, smoking, BMI, estimated glucose disposal rate and estimated glomerular filtration rate (HR: 1.51 [1.27–1.79]). Remnant cholesterol was also higher in those who developed SDR (0.47 [0.36–0.66]) than those who did not (0.40 [0.32–0.53]), P < 0.001, and the concentration increased stepwise with increasing DR severity (P < 0.001). Regarding SDR, the HR for remnant cholesterol was 1.52 (1.26–1.83) with the most stringent adjustment. However, remnant cholesterol variability was not independently associated with the outcomes.Conclusions: Remnant cholesterol concentration, but not variability, predicts DN progression and development of SDR. However, it remains to be elucidated whether the associations are causal or not.

1 September 2021 in The Lancet Diabetes & Endocrinology
Verified
Journal Article
Closed access
VHValma Harjutsalo
Valma Harjutsalo
DBDrazenka Pongrac Barlovic
Drazenka Pongrac Barlovic
PGPer-Henrik Groop
Per-Henrik Groop

16 October 2017 in Diabetes Care
Verified
Journal Article
Closed access
PDF file
HTHeidi Tikkanen-Dolenc
Heidi Tikkanen-Dolenc
JWJohan Wadén
Johan Wadén
CFCarol Forsblom
Carol Forsblom
VHValma Harjutsalo
Valma Harjutsalo
LTLena M. Thorn
Lena M. Thorn
PGPer-Henrik Groop
Per-Henrik Groop
OBJECTIVE The aims of the study were to assess how baseline leisure-time physical activity (LTPA) and its exercise components intensity, duration, and frequency are associated with all-cause and cardiovascular mortality in patients with type 1 diabetes 1) overall, 2) stratified by presence or absence of chronic kidney disease (CKD), and 3) stratified by sex. RESEARCH DESIGN AND METHODS The study design was prospective and observational and included 2,639 patients with type 1 diabetes from the ongoing nationwide multicenter Finnish Diabetic Nephropathy (FinnDiane) Study. Mean follow-up time was 11.4 ± 3.5 years. LTPA was assessed by using a validated self-report questionnaire. Three hundred ten patients (11.7%) had CKD defined as an estimated glomerular filtration rate of ≤60 mL/min/1.73 m2. RESULTS During follow-up, 270 deaths occurred. LTPA and all its components were associated with all-cause mortality, even after adjustment for the potential confounders sex, diabetic nephropathy, duration of diabetes, age at onset of diabetes, systolic blood pressure, triglycerides, BMI, and HbA1c. Only exercise intensity was associated with cardiovascular mortality after adjustment for the confounders. Of the patients with CKD, 127 died during follow-up. The total amount of LTPA and exercise frequency were independently associated with lower risk of all-cause mortality when adjusted for covariates. CONCLUSIONS Exercise is associated with a lower risk of premature all-cause and cardiovascular mortality in patients with type 1 diabetes. This study also demonstrates that physical activity is associated with a lower risk of mortality in patients with type 1 diabetes and CKD.

20 December 2017 in Diabetes Care
Verified
Journal Article
Closed access
PDF file
JHJaakko Helve
Jaakko Helve
RSReijo Sund
Reijo Sund
MAMartti Arffman
Martti Arffman
VHValma Harjutsalo
Valma Harjutsalo
PGPer-Henrik Groop
Per-Henrik Groop
PFPatrik Finne
Patrik Finne
OBJECTIVE: To investigate how risk of end-stage renal disease (ESRD) among patients with type 1 diabetes has changed over time and further how the risk is affected by age, sex, and time period of diagnosis of diabetes. RESEARCH DESIGN AND METHODS: A cohort including all patients <30 years old diagnosed with type 1 diabetes in Finland in 1965–2011 was followed until start of renal replacement therapy, death, or end of follow-up at the end of 2013. Altogether, 29,906 patients were included. The main outcome was cumulative risk of ESRD, accounting for death as a competing risk. RESULTS: The patients were followed up for a median of 20 years. During 616,403 patient-years, 1,543 ESRD cases and 4,185 deaths were recorded. The cumulative risk of ESRD was 2.2% after 20 years and 7.0% after 30 years from the diabetes diagnosis. The relative risk of ESRD was 0.13 (95% CI 0.08–0.22) among patients diagnosed in 1995–2011 compared with those diagnosed in 1965–1979. Patients <5 years old at the time of diagnosis had the lowest risk of ESRD after diagnosis. With the cumulative risk of ESRD estimated from time of birth, the patients aged 5–9 years at diabetes diagnosis were at highest risk. CONCLUSIONS: The cumulative risk of ESRD has decreased markedly during the past five decades. This highlights the importance of modern treatment of diabetes and diabetic nephropathy.